Orkla ASA: Mandatory notification of trade - primary insiders
Orkla ASA (ORK) · publisert 2023-02-14 13:05 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Nian AS | Closely related party to President and CEO Nils Selte | acquisition | 69,08 | 30 000 NOK | 2023-02-14 | NO0003733800 | XOSL – Oslo Stock Exchange | rules · til gjennomgang |
| Audun Stensvold | EVP & Investment Executive | acquisition | 68,97 | 25 000 NOK | 2023-02-14 | NO0003733800 | XOSL – Oslo Stock Exchange | rules · til gjennomgang |
| Maria Syse-Nybraaten | EVP & Investment Executive | acquisition | 69 | 7 000 NOK | 2023-02-14 | NO0003733800 | XOSL – Oslo Stock Exchange | rules |
Vedlegg
- 230214_Attachment_mandatory_notification_NS.pdf (tekst hentet ut)
- 230214_Attachment_mandatory_notification_AS.pdf (tekst hentet ut)
- 230214_Attachment_mandatory_notification_MSN.pdf (tekst hentet ut)
Meldingstekst
Nian AS, a related party to Nils Selte, President & CEO of Orkla, has today, 14
February 2023, bought 30,000 shares in Orkla ASA at a price of NOK 69.08 per
share. The shares were acquired on the Oslo Stock Exchange. Following this
transaction, Selte and personal related parties own 187,395 shares in Orkla ASA.
Audun Stensvold, Executive Vice President, and Investment Executive has today,
14 February 2023, bought 25,000 Orkla shares at a price of NOK 68.97 per share.
The shares were acquired on the Oslo Stock Exchange.
Maria Syse-Nybraaten, Executive Vice President, and Investment Executive has
today, 14 February 2023, bought 7,000 Orkla shares at a price of NOK 69.00 per
share. The shares were acquired on the Oslo Stock Exchange.
For further information, see attachment available at www.newsweb.no.
Orkla ASA
Oslo, 14 February 2023
Ref.:
Investor Relations
Kari Lindtvedt
Tel.: +47 950 75 114
This information is subject to disclosure requirements set out in the Market
Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act
Section 5-12.